Why LIXT? Lixte Biotechnology Holdings, I Analysis, Price & AI Insights | Whystock
LIXT
$5.16+0.23 (+4.67%)
Market ClosedLast close May 8
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.